Cargando…

Hypercalcemia following discontinuation of denosumab therapy: A systematic review

Denosumab is a monoclonal antibody that has been approved to treat osteoporosis, skeletal metastasis, and giant cell tumor of bone in skeletally mature patients. Due to its potential adverse effects on normal bone growth, its use has not yet been approved in skeletally immature patients; however, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Horiuchi, Keisuke, Kobayashi, Eisuke, Mizuno, Tsukasa, Susa, Michiro, Chiba, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605220/
https://www.ncbi.nlm.nih.gov/pubmed/34825020
http://dx.doi.org/10.1016/j.bonr.2021.101148

Ejemplares similares